Next Generation Kinase Inhibitors Summit

by | Feb 23, 2023 | News & Media

February 22-23, 2023

Biolexis Therapeutics Business Development team participated 2nd Next Generation Kinase Inhibitors Summit was held on February 22-23, 2023, in Boston.

14th Annual World Cancer Congress

July 22-24, 2023 Biolexis Therapeutics CSO invited to Chair Cancer Immunology & Immunotherapy session and present MolecuLern technology at 14th Annual World Cancer Congress – WCC 11: Cancer Immunology & Immunotherapy on July 22-24, 2023, at Barcelona, Spain....

22nd Annual Bio-IT World Conference & Expo

May 16-18, 2023 Biolexis CEO Dr. David J. Bearss to present MolecuLern technology at 22nd Annual Bio-IT World Conference & Expo taking place May 16-18, 2023, in Boston, MA. https://www.bio-itworldexpo.com/

Ai-Driven Drug Development Summit

April 26-27, 2023 Biolexis CEO Dr. David J. Bearss to present MolecuLern technology at Ai-Driven Drug Development Summit Europe on April 26-27, 2023, in London. AI Driven Drug Development Summit Europe 2023 (aidrugdevelopmentsummiteu.com)